Response by Sattar et al to Letters Regarding Article, "Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks"

被引：2
|
作者：
Sattar, Naveed [1 ]
Rawshani, Araz [2 ]
Franzen, Stefan [3 ,4 ]
机构：
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[2] Univ Gothenburg, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden
[3] Univ Gothenburg, Hlth Metr Unit, Sahlgrenska Acad, Gothenburg, Sweden
[4] Swedish Natl Diabet Register, Vastra Gotalandsreg, Gothenburg, Sweden
来源：
CIRCULATION | 2019年 / 140卷 / 16期
关键词：
D O I：
10.1161/CIRCULATIONAHA.119.042457
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E724 / E725
页数：2
相关论文
共 50 条
  • [31] Response by Haseeb et al to Letter Regarding Article, "Wine and Cardiovascular Health: A Comprehensive Review"
    Haseeb, Sohaib
    Alexander, Bryce
    Baranchuk, Adrian
    CIRCULATION, 2018, 137 (17) : 1880 - 1881
  • [32] Letter by Aboyans et al Regarding Article, "Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease"
    Aboyans, Victor
    Le Guyader, Alexandre
    Lacroix, Philippe
    CIRCULATION, 2010, 122 (03) : E394 - E394
  • [33] BARIATRIC SURGERY AND RISKS OF RENAL DISEASES, CARDIOVASCULAR DISEASES AND MORTALITY AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Wong, Carlos
    Wu, Tingting
    Wong, Simon
    Law, Betty
    Grieve, Eleanor
    Wu, Olivia
    Lam, Cindy
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1363 - 1363
  • [34] Letter by Xie et al Regarding Article, "Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial"
    Xie, Jian
    Jiang, Mingyang
    Li, Lang
    CIRCULATION, 2019, 139 (22) : E1015 - E1016
  • [35] Response by Pase et al to Letter Regarding Article, "Sweetened Beverages and the Risks of Incident Stroke and Dementia"
    Pase, Matthew P.
    Himali, Jayandra J.
    Seshadri, Sudha
    Jacques, Paul F.
    STROKE, 2017, 48 (09) : E269 - E269
  • [36] Response by Zelniker et al to Letter Regarding Article, "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial"
    Zelniker, Thomas A.
    Raz, Itamar
    Sabatine, Marc S.
    Wiviott, Stephen D.
    CIRCULATION, 2020, 142 (10) : E129 - E130
  • [37] Response by Young et al to Letters Regarding Article, "Cardiac Outcomes After Ischemic Stroke or Transient Ischemic Attack: Effects of Pioglitazone in Patients With Insulin Resistance Without Diabetes Mellitus"
    Young, Lawrence H.
    Viscoli, Catherine M.
    Inzucchi, Silvio E.
    Kernan, Walter N.
    CIRCULATION, 2017, 136 (16) : 1567 - 1568
  • [38] The Relationship between the Risks of Developing Type 2 Diabetes Mellitus and Cardiovascular Diseases
    Sotomayor-Beltran, Carlos
    Perez-Siguas, Rosa
    Matta-Solis, Eduardo
    Matta-Solis, Hernan
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2020, 14 : 13 - 17
  • [39] Type 2 diabetes mellitus - Greater cardiovascular risks and greater benefits of therapy
    Fagan, TC
    Sowers, J
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) : 1033 - 1034
  • [40] Letter by Santos et al Regarding Article, "Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease"
    Teresa Santos, M.
    Moscardo, Antonio
    Valles, Juana
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (04) : E31 - E31
12345